Michael Carpenter

759 total citations
19 papers, 594 citations indexed

About

Michael Carpenter is a scholar working on Infectious Diseases, Molecular Biology and Virology. According to data from OpenAlex, Michael Carpenter has authored 19 papers receiving a total of 594 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 6 papers in Molecular Biology and 5 papers in Virology. Recurrent topics in Michael Carpenter's work include SARS-CoV-2 and COVID-19 Research (3 papers), Bacteriophages and microbial interactions (3 papers) and Poxvirus research and outbreaks (3 papers). Michael Carpenter is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (3 papers), Bacteriophages and microbial interactions (3 papers) and Poxvirus research and outbreaks (3 papers). Michael Carpenter collaborates with scholars based in Canada, United States and Australia. Michael Carpenter's co-authors include A M DeLange, Darryl Falzarano, Hans‐Joachim Schnittler, Masfique Mehedi, Jochen Seebach, Heinz Feldmann, David Schnurr, M. Steven Oberste, Kaija Maher and Margery Kennett and has published in prestigious journals such as PLoS ONE, Journal of Virology and Scientific Reports.

In The Last Decade

Michael Carpenter

18 papers receiving 586 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Carpenter Canada 11 264 199 123 117 115 19 594
Inge Thoelen Belgium 11 529 2.0× 175 0.9× 195 1.6× 120 1.0× 53 0.5× 17 826
Marcus Picard‐Maureau Germany 11 138 0.5× 279 1.4× 33 0.3× 129 1.1× 103 0.9× 13 541
Ila Singh United States 12 156 0.6× 168 0.8× 37 0.3× 157 1.3× 93 0.8× 32 575
Nathalie Schnepf France 14 191 0.7× 220 1.1× 64 0.5× 38 0.3× 31 0.3× 24 525
Sébastien Hantz France 17 277 1.0× 583 2.9× 36 0.3× 73 0.6× 61 0.5× 75 873
Hitoshi Oshitani Japan 12 200 0.8× 527 2.6× 37 0.3× 132 1.1× 26 0.2× 29 655
Kathleen Todd United States 7 103 0.4× 259 1.3× 48 0.4× 189 1.6× 13 0.1× 13 528
María Teresa Cuevas Spain 19 574 2.2× 353 1.8× 24 0.2× 142 1.2× 600 5.2× 44 898
Zhikai Xu China 17 442 1.7× 388 1.9× 29 0.2× 198 1.7× 12 0.1× 60 777
Sam Nooij Netherlands 11 289 1.1× 106 0.5× 19 0.2× 204 1.7× 16 0.1× 16 507

Countries citing papers authored by Michael Carpenter

Since Specialization
Citations

This map shows the geographic impact of Michael Carpenter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Carpenter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Carpenter more than expected).

Fields of papers citing papers by Michael Carpenter

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Carpenter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Carpenter. The network helps show where Michael Carpenter may publish in the future.

Co-authorship network of co-authors of Michael Carpenter

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Carpenter. A scholar is included among the top collaborators of Michael Carpenter based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Carpenter. Michael Carpenter is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Wood, Heidi, Teresa Cabral, Chris K. Grant, et al.. (2024). Development and characterization of monoclonal antibodies recognizing nucleocapsid protein of multiple SARS-CoV-2 variants. Heliyon. 10(15). e35325–e35325. 1 indexed citations
2.
Calkins, Frederick T., et al.. (2023). Remote control actuated wind tunnel models: design and testing best practices. AIAA SCITECH 2023 Forum.
3.
Deschambault, Yvon, Bryce M. Warner, Kevin Tierney, et al.. (2022). Single Immunization with Recombinant ACAM2000 Vaccinia Viruses Expressing the Spike and the Nucleocapsid Proteins Protects Hamsters against SARS-CoV-2-Caused Clinical Disease. Journal of Virology. 96(9). e0038922–e0038922. 8 indexed citations
4.
Cabral, Teresa, Kathy Manguiat, Alyssia Robinson, et al.. (2021). Development and characterization of SARS-CoV-2 variant-neutralizing monoclonal antibodies. Antiviral Research. 196. 105206–105206. 2 indexed citations
5.
Calkins, Frederick T., et al.. (2019). Low & High Speed Cryogenic Testing of a Wind Tunnel Model With Remote Control Actuation (RCA) Spoiler. AIAA Aviation 2019 Forum. 3 indexed citations
6.
Ranadheera, Charlene, Shane Jones, Allen Grolla, et al.. (2018). The interaction between the Nipah virus nucleocapsid protein and phosphoprotein regulates virus replication. Scientific Reports. 8(1). 15994–15994. 22 indexed citations
7.
Cheng, Keding, Angela Sloan, Robert Vendramelli, et al.. (2017). Altered rPrP substrate structures and their influence on real-time quaking induced conversion reactions. Protein Expression and Purification. 143. 20–27. 3 indexed citations
8.
Mangat, Chand S., David A. Boyd, Nicol Janecko, et al.. (2016). Characterization of VCC-1, a Novel Ambler Class A Carbapenemase from Vibrio cholerae Isolated from Imported Retail Shrimp Sold in Canada. Antimicrobial Agents and Chemotherapy. 60(3). 1819–1825. 40 indexed citations
9.
Jackson, Alan C., Wafa Kammouni, Heidi Wood, & Michael Carpenter. (2016). Rabies virus infection: Role of the rabies virus phosphoprotein in producing neuronal injury mediated by mitochondrial dysfunction and oxidative stress. International Journal of Infectious Diseases. 45. 438–438. 2 indexed citations
11.
Stein, Derek R., Stuart McCorrister, Garrett Westmacott, et al.. (2013). High pH reversed‐phase chromatography as a superior fractionation scheme compared to off‐gel isoelectric focusing for complex proteome analysis. PROTEOMICS. 13(20). 2956–2966. 34 indexed citations
12.
Mehedi, Masfique, Darryl Falzarano, Jochen Seebach, et al.. (2011). A New Ebola Virus Nonstructural Glycoprotein Expressed through RNA Editing. Journal of Virology. 85(11). 5406–5414. 143 indexed citations
13.
Burgener, Adam, Charles Wachihi, Joshua Kimani, et al.. (2008). Identification of Differentially Expressed Proteins in the Cervical Mucosa of HIV-1-Resistant Sex Workers. Journal of Proteome Research. 7(10). 4446–4454. 68 indexed citations
14.
Johnson, Paul M., et al.. (2002). Recipient Cells Form the Intimal Proliferative Lesion in the Rat Aortic Model of Allograft Arteriosclerosis. American Journal of Transplantation. 2(3). 207–214. 31 indexed citations
15.
Oberste, M. Steven, Kaija Maher, Margery Kennett, et al.. (1999). Molecular Epidemiology and Genetic Diversity of Echovirus Type 30 (E30): Genotypes Correlate with Temporal Dynamics of E30 Isolation. Journal of Clinical Microbiology. 37(12). 3928–3933. 119 indexed citations
16.
DeLange, A M, et al.. (1995). An etoposide-induced block in vaccinia virus telomere resolution is dependent on the virus-encoded DNA ligase. Journal of Virology. 69(4). 2082–2091. 10 indexed citations
17.
Carpenter, Michael, et al.. (1994). The Vaccinia Virus-Encoded Uracil DNA Glycosylase Has an Essential Role in Viral DNA Replication. Virology. 198(2). 504–513. 57 indexed citations
18.
Carpenter, Michael, et al.. (1992). Identification of a temperature-sensitive mutant of vaccinia virus defective in late but not intermediate gene expression. Virology. 188(1). 233–244. 13 indexed citations
19.
Carpenter, Michael & A M DeLange. (1991). A temperature-sensitive lesion in the small subunit of the vaccinia virus-encoded mRNA capping enzyme causes a defect in viral telomere resolution. Journal of Virology. 65(8). 4042–4050. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026